RU2002118304A - Способ подавления чувства страха - Google Patents

Способ подавления чувства страха

Info

Publication number
RU2002118304A
RU2002118304A RU2002118304/14A RU2002118304A RU2002118304A RU 2002118304 A RU2002118304 A RU 2002118304A RU 2002118304/14 A RU2002118304/14 A RU 2002118304/14A RU 2002118304 A RU2002118304 A RU 2002118304A RU 2002118304 A RU2002118304 A RU 2002118304A
Authority
RU
Russia
Prior art keywords
fear
way
suppress feelings
feelings
suppress
Prior art date
Application number
RU2002118304/14A
Other languages
English (en)
Other versions
RU2254132C2 (ru
Inventor
Роберт Ф. МЭЙОЛ (US)
Роберт Ф. МЭЙОЛ
Original Assignee
Бристол-Маерс Сквибб Компани (Us)
Бристол-Маерс Сквибб Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27047894&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2002118304(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бристол-Маерс Сквибб Компани (Us), Бристол-Маерс Сквибб Компани filed Critical Бристол-Маерс Сквибб Компани (Us)
Publication of RU2002118304A publication Critical patent/RU2002118304A/ru
Application granted granted Critical
Publication of RU2254132C2 publication Critical patent/RU2254132C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Claims (1)

  1. Способ подавления чувства страха у млекопитающего, заключающийся в системном введении млекопитающему эффективной, но не токсичной анксиолитической дозы 6-гидрокси-8-[4-[4-(2-пиримидинил)-пиперазинил]-бутил]-8-азаспиро[4.5]-7,9-диона или его фармацевтически приемлемой соли присоединения кислоты или его гидрата.
RU2002118304/14A 2000-01-18 2000-10-18 Способ подавления чувства страха RU2254132C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48416100A 2000-01-18 2000-01-18
US09/484,161 2000-01-18
US09/588,221 2000-06-06
US09/588,221 US6150365A (en) 1999-08-05 2000-06-06 Anxiety method

Publications (2)

Publication Number Publication Date
RU2002118304A true RU2002118304A (ru) 2004-01-10
RU2254132C2 RU2254132C2 (ru) 2005-06-20

Family

ID=27047894

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002118304/14A RU2254132C2 (ru) 2000-01-18 2000-10-18 Способ подавления чувства страха

Country Status (22)

Country Link
US (1) US6150365A (ru)
EP (1) EP1248622B1 (ru)
JP (1) JP2003520236A (ru)
KR (1) KR20020073176A (ru)
CN (1) CN1424911A (ru)
AR (1) AR028201A1 (ru)
AT (1) ATE300302T1 (ru)
AU (1) AU775591B2 (ru)
BR (1) BR0016971A (ru)
CA (1) CA2406732A1 (ru)
CZ (1) CZ20022461A3 (ru)
DE (1) DE60021609D1 (ru)
HU (1) HUP0204285A3 (ru)
IL (1) IL150019A0 (ru)
MX (1) MXPA02007003A (ru)
NO (1) NO20023425L (ru)
NZ (1) NZ520823A (ru)
PL (1) PL355966A1 (ru)
RU (1) RU2254132C2 (ru)
TW (1) TWI226831B (ru)
UY (1) UY26440A1 (ru)
WO (1) WO2001052853A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150365A (en) * 1999-08-05 2000-11-21 Bristol-Myers Squibb Company Anxiety method
US20030069251A1 (en) * 1999-08-05 2003-04-10 Yevich Joseph P. Antianxiety composition
US20050137206A1 (en) * 1999-08-05 2005-06-23 Yevich Joseph P. Method for treatment of anxiety and depression
JP2005502318A (ja) * 2001-03-22 2005-01-27 メルク　エンド　カムパニー　インコーポレーテッド Ｍｃｈ１ｒ欠損マウス
US6593331B2 (en) 2001-04-17 2003-07-15 Laboratories Upsa Method for treatment of pain
EP1408979A4 (en) * 2001-07-24 2005-03-23 Bristol Myers Squibb Co R-6-HYDROXY-BUSPIRONE
EP1417203A4 (en) * 2001-07-24 2005-08-10 Bristol Myers Squibb Co S-6-HYDROXY-BUSPIRONE
PL374000A1 (en) * 2002-08-12 2005-09-19 Bristol-Myers Squibb Company Improved process for hydroxyazapirones
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
CA2514574A1 (en) * 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Use of sodium channel modulators for treating gastrointestinal tract disorders
BR112013009004B1 (pt) 2010-10-15 2022-05-10 Contera Pharma Aps Uso de composição farmacêutica ou kit de partes compreendendo combinações de agonistas dereceptor de serotonina
IN2014DN09571A (ru) 2012-04-18 2015-07-17 Contera Pharma Aps
PT3160464T (pt) 2014-06-26 2018-10-12 Contera Pharma Aps 6-hidroxibuspirona para uso no tratamento de transtornos do movimento
CA3030089C (en) 2016-07-11 2024-04-23 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4409223A (en) * 1982-08-06 1983-10-11 Riblet Leslie A Anxiolytic method
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
WO1998024411A2 (en) * 1996-12-04 1998-06-11 Bristol-Myers Squibb Company Method for oral administration of buspirone
US6150365A (en) * 1999-08-05 2000-11-21 Bristol-Myers Squibb Company Anxiety method

Also Published As

Publication number Publication date
JP2003520236A (ja) 2003-07-02
HUP0204285A3 (en) 2004-07-28
UY26440A1 (es) 2001-08-27
IL150019A0 (en) 2002-12-01
NO20023425D0 (no) 2002-07-17
HUP0204285A2 (en) 2003-05-28
ATE300302T1 (de) 2005-08-15
WO2001052853A1 (en) 2001-07-26
PL355966A1 (en) 2004-05-31
CZ20022461A3 (cs) 2003-09-17
MXPA02007003A (es) 2003-01-28
BR0016971A (pt) 2002-10-15
CA2406732A1 (en) 2001-07-26
AU775591B2 (en) 2004-08-05
US6150365A (en) 2000-11-21
EP1248622B1 (en) 2005-07-27
AU1213001A (en) 2001-07-31
NO20023425L (no) 2002-09-05
AR028201A1 (es) 2003-04-30
KR20020073176A (ko) 2002-09-19
EP1248622A1 (en) 2002-10-16
DE60021609D1 (de) 2005-09-01
EP1248622A4 (en) 2004-02-04
RU2254132C2 (ru) 2005-06-20
NZ520823A (en) 2004-05-28
TWI226831B (en) 2005-01-21
CN1424911A (zh) 2003-06-18

Similar Documents

Publication Publication Date Title
RU2002118304A (ru) Способ подавления чувства страха
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
MX2007003321A (es) Derivados heterociclicos y su uso como agentes terapeuticos.
WO2006034341A3 (en) Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
WO2005049581A8 (en) Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
DE60142469D1 (de) Imidinderivate als antineoplastika
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
WO2005011655A3 (en) Pyridazine derivatives and their use as therapeutic agents
WO2005011653A3 (en) Pyridazine derivatives and their use as therapeutic agents
NO20052927L (no) 2,4,6-trisubstituerte pyrimidiner av fosfotidylinositol (PI) 3-kinaseinhibitorer og deres anvendelse ved behandling av kreft
DE60316013D1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
CR10114A (es) Composiciones farmacéuticas que comprenden inhibidoras de la hmg coa reductasa (divisional del exp. 6687)
ES2195785A1 (es) Nuevos derivados de piridazin-3(2h)-ona.
ATE284861T1 (de) N-aralkylaminotetraline als neuropeptid-y-y5- rezeptorliganden
DE50102597D1 (de) Arzneimittel gegen virale erkrankungen
ATE384724T1 (de) Cyclopropylverbindungen als ccr5 antagonisten
NO20020662D0 (no) Pyrimidin-2,4,6-trion metalloproteinase inhibitorer
ATE405269T1 (de) Cyclohexylverbindungen als ccr5-antagonisten
WO2003022216A3 (en) Biaryl substituted purine derivatives as potent antiproliferative agents
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
DE60324014D1 (de) Heterocyclische verbindungen alsccr5-antagonisten
WO2003022219A3 (en) Biarylamino purine antiproliferative agents
WO2003022805A3 (en) Heterocycle substituted purines as antiproliferative agents
WO2004014868A3 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20051019